(A011202) A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 NI) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
Description: 

To evaluate whether axillary radiation alone is not inferior to axillary radiation and axillary lymph node dissection (ALND) in terms of invasive breast cancer recurrence-free interval in patients with positive SLN(s) after completion of neoadjuvant chemotherapy.

Study Number: 

NCG 245113

Phase: 
III
Principal Investigator: 
ClinicalTrials.Gov ID: 
NCT01901094

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.